Not only generic medicines or the ingredients used to produce them but also original reference medicines and their constituent parts can come from anywhere in the world. What matters, however, is that the Finnish and EU regulatory authorities are familiar with the pharmaceutical plants where the medicinal products or ingredients destined for the Finnish market originate.
Inspectors from Finland and other EU member states conduct inspections in production facilities across the world. The real question is not where the products are manufactured but what quality standards and testing methods are applied. Both China and India have a highly sophisticated pharmaceutical industry – comparable to their electronics research and industry.
10 Nov 2015